Volume 5, Number 2Review ArticlesModern Tumor Marker Discovery in Urology: Surface Enhanced Laser Desorption and Ionization (SELDI)Technique UpdateAlan W PartinMatthew B GretzerRobert W VeltriDaniel W ChanProstate cancerBladder cancerRenal cancerMarkersProteomics
Volume 12, Number 3Meeting ReviewsUro-Oncological Controversies in Euro-OncologyMeeting ReviewHerbert LeporBob DjavanAlexander FarrElisabeth EckersbergerHelen SadriMarkus MargreiterMike HarikHighlights From the European Association of Urology Section of Oncological Urology, January 15-17, 2010, Vienna, Austria [Rev Urol. 2010;12(2/3):e125-e128 doi: 10.3909/riu0491]Prostate cancer screeningBladder cancerRenal cancerRoboticsCancer mortality rates
Volume 16, Number 2Review ArticlesSolitary Renal Fossa Recurrence of Renal Cell Carcinoma After NephrectomyTreatment ReviewKamran AhmedJi-Jian ChowZahoor FaziliMohammed SheikhMartin SheriffRenal cell carcinoma without metastasis responds well to surgical excision but is known to recur postnephrectomy. In a small but significant number of patients this recurrence is not accompanied by metastasis, which is important as these people benefit from further surgery. We examined 20 articles from the current literature to ascertain how best to treat this condition. Surgical management renders better results than conservative or medical therapies. Readily available investigations such as blood tests and computed tomography can help determine the right patients for surgery in an evidence-based fashion. Current findings have allowed us to suggest a protocol for the treatment of solitary renal fossa recurrence of postnephrectomy renal cell carcinoma. There are further opportunities for study in validating our protocol, and in novel renal cell carcinoma treatment strategies that have not been tested on solitary renal fossa recurrences. [Rev Urol. 2014;16(2):76-82 doi: 10.3909/riu0598] © 2014 MedReviews®, LLCComplicationsManagementRenal cancerRecurrenceNephrectomy